Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

WEDI Offers Complimentary ICD-10 Compliance Training Through Webinar Series

Reston, VA, February 10, 2014 -- The Workgroup for Electronic Data Interchange (WEDI) in partnership with the Centers for Medicare and Medicaid Services (CMS), the Cooperative Exchange and other private industry partners, today announced the launch of its ICD-10 Success Initiative webinar series. The purpose of these webinars is to help health IT stakeholders meet the October 1 ICD-10 compliance deadline and to provide answers to common questions.

AMA: ICD-10 costs ‘dramatically’ higher than estimates

ICD-10 implementation will cost physicians “dramatically” more than previously estimated, according to a cost study initiated by the American Medical Association (AMA) and conducted by Nachimson Advisors.

Bloomberg News: Administration's Studies of New Payment Systems Employ Faulty Data Analysis

The government's release of first-year cost-savings results for its accountable care organization (ACO) project and the Centers for Medicare and Medicaid Services (CMS) Innovation Center delivery system reform pilot projects have drawn criticism from both the New York Times and the Washington Post, which published articles pointing out the problems with drawing conclusions from studies that are not true randomized controlled trials. In short, correlation is not causation, and the early results, while interesting, are not the same as proof that ACOs and new reimbursement methods like bundled payments actually deliver better care more cheaply. In a commentary, Bloomberg News summarized the controversy.

Bill targets ‘overregulation’ in health IT industry

Senators Deb Fischer (R-Neb.) and Angus King (I-Maine) announced legislation that would limit FDA’s regulatory oversight to focus on products that pose the greatest health risks.

Thumbnail

5 Things the SGR Bill Does Besides Fix Doc Pay

The H.R. 4015/S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, bills also contain provisions that impact more than just physician pay. Among the provisions tucked inside the bill are these five.

Thumbnail

CMS extends EHR attestation deadline by one month

The Centers for Medicare & Medicaid Services is giving eligible professionals an additional month to attest to Meaningful Use for the Medicare EHR incentive program 2013 reporting period. The announcement effectively pushes back the deadline from Feb. 28 to March 31.

Thumbnail

This week in health IT: Focus on federal mandates

Two of the biggest federal mandates facing providers this year were in the news this week—for good and bad reasons.

HITPC: MU workgroup previews Stage 3 recommendations

Clinical decision support, patient engagement, care coordination and population management are the four areas of special emphasis reflected in Meaningful Use Stage 3 draft recommendations, Paul Tang, MD, MS, Palo Alto Medical Foundation and chair of the MU workgroup, said at the Health IT Policy Committee meeting on Feb. 4.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.